Adverse drug reactions in TB therapy: risks and recommendations.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004341:Drug Evaluation; D004977:Ethambutol / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced; D008875:Middle Aged; D009902:Optic Neuritis / Q000139:chemically induced; D012293:Rifampin / Q000009:adverse effects; D012306:Risk; D013307:Streptomycin / Q000009:adverse effects; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D004977:Ethambutol; D001219:Aspartate Aminotransferases; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin